ciprofloxacin has been researched along with Rhinoscleroma in 15 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Rhinoscleroma: A granulomatous disease caused by KLEBSIELLA RHINOSCLEROMATIS infection. Despite its name, this disease is not limited to the nose and NASOPHARYNX but may affect any part of the RESPIRATORY TRACT, sometimes with extension to the lip and the skin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Klebsiella rhinoscleromatis is the causative agent of this infection and the Mikulicz cell is specific to the lesion being a large macrophage with clear cytoplasm containing the bacilli." | 5.31 | A case of rhinoscleroma treated with ciprofloxacin. ( Badia, L; Lund, VJ, 2001) |
| "Rhinoscleroma is a granulomatous infection of the nasal cavities due to enteric bacterium belonging to the Klebsiella family (Klebsiella rhinoscleromatis)." | 1.48 | [Rhinoscleroma: a rare chronic infection of the nasal cavities]. ( Ghorbel, AM; Kallel, S, 2018) |
| "Rhinoscleroma is a chronic infectious disease that is endemic in certain poor areas of the world." | 1.48 | Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases. ( Ben Mansour, N; Chbani, L; Efared, B; El Fatemi, H; Gabrielle, AE; Hammas, N, 2018) |
| "Rhinoscleroma is a specific granulomatous and chronic disorder with insidious evolution." | 1.48 | [Rhinoscleroma of the cavum with expression in cervical lymph nodes: about a case]. ( Benayad, J; Benbouzid, MA; El Ayoubi, A; Essakalli, L; Lachhab, O; Lassikri, O, 2018) |
| "Klebsiella rhinoscleromatis is the causative agent of this infection and Mikulicz cells are specific to this lesion." | 1.42 | Rhinoscleroma of nose extruding into oral cavity. ( Desai, D; Ingaleshwar, PS; K V, S; Nayak, P; Pandit, S; R C, P, 2015) |
| "Rhinoscleroma is a chronic, slowly progressive, inflammatory disease of the upper respiratory tract." | 1.38 | Rhinoscleroma: a case series. ( Neoh, CY; Tan, HH; Tan, SL, 2012) |
| "Rhinoscleroma has become a more and more rare disease because of the sensitivity to the new molecules." | 1.37 | Retrospective study of the rhinoscleroma about 14 cases in ENT departments of university hospitals (Côte d'Ivoire). ( Kacouchia, N; Koffi-N'guessan, L; Kouassi, M; Kouassi-Ndjeundo, J; Mobio, NM; N'gattia, KV; Vroh Bi, TS; Yoda, M, 2011) |
| "Klebsiella rhinoscleromatis is the causative agent of this infection and the Mikulicz cell is specific to the lesion being a large macrophage with clear cytoplasm containing the bacilli." | 1.31 | A case of rhinoscleroma treated with ciprofloxacin. ( Badia, L; Lund, VJ, 2001) |
| "Rhinoscleroma is a very rare cause of upper airway obstruction with only isolated reports in the literature of rhinoscleroma with isolated tracheal obstruction." | 1.31 | Upper airway obstruction due to rhinoscleroma: case report. ( Al Jahdali, H; Al Othman, A; Al-Zuwayed, M; Bamefleh, H; Memish, Z, 2001) |
| "Rhinoscleroma is a rare infectious disease of the upper respiratory tract caused by Klebsiella rhinoscleromatis." | 1.30 | [Rhinoscleroma: a case report]. ( Bodlaj, R; Issing, WJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sadek, HS | 1 |
| El-Marssafy, LH | 1 |
| Hussein, FF | 1 |
| Kallel, S | 1 |
| Ghorbel, AM | 1 |
| Gamea, M | 1 |
| El Tatawi, F | 1 |
| Elnaggar, A | 1 |
| Elafandi, H | 1 |
| Ebeid, K | 1 |
| Efared, B | 1 |
| Hammas, N | 1 |
| Gabrielle, AE | 1 |
| Ben Mansour, N | 1 |
| El Fatemi, H | 1 |
| Chbani, L | 1 |
| Lassikri, O | 1 |
| Benayad, J | 1 |
| Lachhab, O | 1 |
| El Ayoubi, A | 1 |
| Benbouzid, MA | 1 |
| Essakalli, L | 1 |
| Nayak, P | 1 |
| R C, P | 1 |
| K V, S | 1 |
| Desai, D | 1 |
| Pandit, S | 1 |
| Ingaleshwar, PS | 1 |
| Ramachandran, P | 1 |
| Piquette, C | 1 |
| Poole, JA | 1 |
| N'gattia, KV | 1 |
| Kacouchia, N | 1 |
| Koffi-N'guessan, L | 1 |
| Mobio, NM | 1 |
| Kouassi-Ndjeundo, J | 1 |
| Kouassi, M | 1 |
| Yoda, M | 1 |
| Vroh Bi, TS | 1 |
| Tan, SL | 1 |
| Neoh, CY | 1 |
| Tan, HH | 1 |
| Avery, RK | 1 |
| Salman, SD | 1 |
| Baker, AS | 1 |
| Borgstein, J | 1 |
| Sada, E | 1 |
| Cortes, R | 1 |
| Issing, WJ | 1 |
| Bodlaj, R | 1 |
| Fajardo-Dolci, G | 1 |
| Chavolla, R | 1 |
| Lamadrid-Bautista, E | 1 |
| Rizo-Alvarez, J | 1 |
| Badia, L | 1 |
| Lund, VJ | 1 |
| Al Jahdali, H | 1 |
| Bamefleh, H | 1 |
| Memish, Z | 1 |
| Al-Zuwayed, M | 1 |
| Al Othman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gemifloxacin Versus Ciprofloxacin Versus Rifampicin in Treatment of Rhinoscleroma[NCT03326050] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2018-02-28 | Not yet recruiting | ||
| Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma[NCT05431673] | Phase 1 | 45 participants (Anticipated) | Interventional | 2022-08-21 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ciprofloxacin and Rhinoscleroma
| Article | Year |
|---|---|
Ciprofloxacin for rhinoscleroma and ozena.
Topics: Ciprofloxacin; Female; Humans; Male; Rhinitis, Atrophic; Rhinoscleroma; Rifampin; Trimethoprim, Sulf | 1993 |
14 other studies available for ciprofloxacin and Rhinoscleroma
| Article | Year |
|---|---|
First report of rare persistence granulomatous extra respiratory Rhinoscleroma of oral pathology.
Topics: Ciprofloxacin; Female; Humans; Nasal Cavity; Nose; Pathology, Oral; Rhinoscleroma | 2022 |
[Rhinoscleroma: a rare chronic infection of the nasal cavities].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Female; Humans; Klebsiella pneumoni | 2018 |
Topical ciprofloxacin as treatment for rhinoscleroma in a series of 23 patients.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Ma | 2021 |
Rhinoscleroma: a chronic infectious disease of poor areas with characteristic histological features - report of a series of six cases.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Chronic Disease; Ciprofloxacin; Female; Humans; Mal | 2018 |
[Rhinoscleroma of the cavum with expression in cervical lymph nodes: about a case].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Female; Follow-Up Studies; Humans; Klebsiella pneumoniae; Lymp | 2018 |
Rhinoscleroma of nose extruding into oral cavity.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Middle Aged; Mouth; Nas | 2015 |
Rhinoscleroma in a young adult with chronic rhinitis and dyspnea.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Dyspnea; Female; Humans; Klebsiella pneumoniae; Nasal O | 2008 |
Retrospective study of the rhinoscleroma about 14 cases in ENT departments of university hospitals (Côte d'Ivoire).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality | 2011 |
Rhinoscleroma: a case series.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; | 2012 |
Rhinoscleroma treated with ciprofloxacin: a case report.
Topics: Adult; Ciprofloxacin; Humans; Male; Rhinoscleroma; Treatment Outcome | 1995 |
[Rhinoscleroma: a case report].
Topics: Adult; Ciprofloxacin; Combined Modality Therapy; Endoscopy; Humans; Klebsiella pneumoniae; Male; Nas | 1999 |
Laryngeal scleroma.
Topics: Adult; Airway Obstruction; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Laryngeal Diseases; | 1999 |
A case of rhinoscleroma treated with ciprofloxacin.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Rhinos | 2001 |
Upper airway obstruction due to rhinoscleroma: case report.
Topics: Airway Obstruction; Anti-Infective Agents; Bronchoscopy; Ciprofloxacin; Dyspnea; Female; Gram-Negati | 2001 |